Isracann Biosciences Inc. (ISCNF)

USD 0.0

(0.0%)

Annual Income Statements

(In CAD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - 1.17 Million
Cost of Revenue - 41.73 Thousand 41.3 Thousand 45.12 Thousand 44.84 Thousand -
Gross Profit - -41.73 Thousand -41.3 Thousand -45.12 Thousand -44.84 Thousand 1.17 Million
Operating Expenses - 2.54 Million 4.93 Million 11.77 Million 5.66 Million 7.45 Million
Selling, General and Administrative Expenses - 2.5 Million 4.89 Million 11.72 Million 5.61 Million 6.87 Million
Research and Development Expenses - - - - - -
Other Expenses - - -2060.00 - - -
Cost and Expenses - 2.54 Million 4.93 Million 11.77 Million 5.66 Million 7.45 Million
Operating Income - -3.93 Million -4.85 Million -11.63 Million -5.66 Million -6.28 Million
Interest Expense - 14.14 Thousand 139.42 Thousand - - 120.06 Thousand
Income Tax Expense - -1.46 Million 31.03 Thousand -68.5 Thousand 175.32 Thousand 120.06 Thousand
Earnings before Tax - -4.69 Million -25.09 Million -23.98 Million -5.59 Million -7.47 Million
Net Income - -4.69 Million -25.15 Million -24.2 Million -9.59 Million -7.47 Million
Earnings Per Share Basic - -0.03 -0.18 -0.26 -0.75 -0.33
Earnings Per Share Diluted - -0.03 -0.18 -0.26 -0.75 -0.33
Weighted Average Shares Outstanding - 147.75 Million 138.4 Million 92.75 Million 12.77 Million 22.61 Million
Weighted Average Shares Outstanding (Diluted) - 147.75 Million 138.4 Million 92.75 Million 12.77 Million 22.61 Million
Gross Margin - - - - - 1.00
EBIT Margin - - - - - -4.86
Profit Margin - - - - - -6.37
EBITDA - -3.89 Million -4.81 Million -11.58 Million -5.61 Million -5.69 Million
Earnings Before Tax Margin - - - - - -5.35

Income Statement Charts